17d
ZNetwork on MSNWith Only 70 Months Left to End AIDS, Why Is the Urgency Missing?The global AIDS response is not only off-the-target but also slipping by leaps and bounds in some countries or for some communities. All governments promised to end AIDS by 2030 by committing to the ...
The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...
ANI Pharmaceuticals (ANIP) announced that the U.S. FDA has approved an expanded label for Iluvien that includes an indication for the treatment ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for osteoporosis and bone loss in various patient populations. Stoboclo and ...
If you continue to have this issue please contact [email protected]. Encelto is the first FDA-approved treatment for macular telangiectasia type 2. The cell therapy slows the loss of ...
The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results